Monopar Therapeutics Inc (MNPR) stock news · $431.4M cap
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
This MNPR news page leads with what Monopar Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for MNPR yet. We will not pad this page with generic market recap.
Latest reported MNPR revenue for 2025-12-31 was $0. Net income was -$13.7M. MNPR currently screens at market cap $431.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MNPR stock page; for the tape open the quote page.
MNPR stock news FAQ
What is MNPR's latest net income?
Latest cached Monopar Therapeutics Inc (MNPR) net income was -$13.7M. Statements: https://lician.com/financials/mnpr
What is MNPR's market cap?
Monopar Therapeutics Inc (MNPR) market cap is $431.4M on the latest cached fundamentals snapshot.
What kind of company is MNPR?
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Where is MNPR stock news listed?
Cached stock news for Monopar Therapeutics Inc (MNPR) is listed at https://lician.com/news/mnpr. Filings: https://lician.com/sec/mnpr
Not investment advice.